Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF
Last | 5:38 PM CET
297.05quote price arrow down-5.50 (-1.82%)
Volume
1,363,120
52 week range
265.75 - 357.85

...

Loading . . .

KEY STATS

  • Open303.00
  • Day High303.55
  • Day Low297.05
  • Prev Close302.55
  • 52 Week High357.85
  • 52 Week High Date04/28/20
  • 52 Week Low265.75
  • 52 Week Low Date03/16/20
  • Market Cap282,756.45M
  • Shares Out853.13M
  • 10 Day Average Volume1.45M
  • Dividend9.10
  • Dividend Yield3.06%
  • Beta0.08
  • 1 Year % Change-10.01

RATIOS/PROFITABILITY

  • EPS (TTM)16.52
  • P/E (TTM)17.98
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO4:0804:08
Weill Neurohub joins Genentech and Roche in accelerating neuroscience research

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland